deucravacitinib
bms
['deucra']
new sle rx. deucravitinib a tyk2i phase 2 rct showed sri4 endpoint. subset of 3 mg bid was best vs 6 mg bid and 12 mg od. skin via clasi-50 &amp; other endpoints also positive. awaiting phase iii. abst1117 #acr22 
not so new at tweeting but always opinionated